Enhancing Corporate Value and Sharing Value with Shareholders Through Performance-Based Stock Options
First written in FY2023-Q1. 9 of 11 entries say "Advanced", first in FY2023-Q3. Latest entry: FY2027-H1.
0 other companies' latest entry also says "Advanced".
- FY2027-H1AdvancedAnnual report
「14th Series of Stock Acquisition Rights Resolution date Resolution of the annual general meeting of shareholders held on 28 April 2026 (resolution of the Board of Directors dated 27 May 2026) Category and number of grantees (people) Director of a subsidiary 1 Number of stock acquisition rights (rights) 100 Class, details and number of shares underlying the stock acquisition rights (shares) Common shares 10,000」
Under a share-based compensation scheme subject to performance conditions, 100 rights covering 10,000 shares were issued to 1 director of a subsidiary under the 14th Series of Stock Acquisition Rights. - FY2026AdvancedAnnual report
「Series 14 stock acquisition rights Number of stock acquisition rights (units) 100 (maximum) Class, details and number of shares underlying the stock acquisition rights (shares) Common shares 10,000」
At the annual general meeting of shareholders held after the filing, the issuance of stock options covering up to 10,000 shares as Series 14 stock acquisition rights was approved. The company also indicated a policy of attaching performance conditions that contribute to sustainable growth. - FY2025-H1Partial lapse of existing stock acquisition rightsAnnual report
「The Series 10-A stock acquisition rights approved at the Board of Directors meeting held on 19 May 2022 and the Series 10-B stock acquisition rights approved at the Board of Directors meeting held on 22 July 2022 have partially lapsed because the exercise conditions were not met.」
It states that part of the existing performance-linked stock acquisition rights lapsed because the exercise conditions were not met. - FY2025-Q1AdvancedAnnual report
「A holder of stock acquisition rights may exercise the rights only if revenue, operating profit and return on equity (ROE) in the consolidated statement of income in the company's financial statements exceed the thresholds specified below. The number that may be exercised is limited to the number of rights allocated to each holder multiplied by the applicable percentage specified below (the “exercise availability percentage”). Any fractional amount of less than 1 right is rounded down. (a) If revenue for the fiscal year ending January 2027 exceeds ¥12.5 billion, operating profit exceeds ¥1.13 billion and ROE exceeds 18%: exercise availability percentage 50%. (b) If revenue for the fiscal year ending January 2030 exceeds ¥20.6 billion, operating profit exceeds ¥2.06 billion and ROE exceeds 18%: exercise availability percentage 50%.」
It issued new stock options and established two-stage performance-linked conditions based on revenue, operating profit and ROE for the fiscal years ending January 2027 and January 2030. - FY2024-Q1AdvancedAnnual report
「At a meeting of the Board of Directors held on 19 May 2023, the company resolved to issue stock acquisition rights as stock options to its executive officers and employees and to directors of its subsidiaries, excluding the company's directors, and issued them on 1 June 2023.」
Under the existing performance-linked stock option program, the company issued 600 stock acquisition rights covering 60,000 shares to 4 executive officers, 1 employee and 1 subsidiary director. The exercise period is from 20 May 2025 to 19 May 2033. - FY2023-Q3AdvancedAnnual report
「Series 10-B stock acquisition rights Category and number of eligible persons (people) Directors of subsidiaries 1 Number of stock acquisition rights (units) 96 Class, details and number of shares underlying the stock acquisition rights (shares) Common shares 9,600」
On 1 September 2022, the company issued 96 Series 10-B stock acquisition rights covering 9,600 shares to 1 subsidiary director. The existing performance-linked equity compensation program has been extended to subsidiary officers. - FY2023-Q1First statedAnnual report
「The company will issue stock acquisition rights as stock options for its directors, executive officers and employees, with the aim of providing incentives for the sustained enhancement of corporate value and promoting greater value sharing with shareholders.」
On 1 June 2022, the company issued 704 stock acquisition rights covering 70,400 shares. The exercise conditions set revenue and operating profit targets for the fiscal years ending January 2023 and January 2024, with exercise availability set at 50% or 100%.